Thermal Therapy of Cancer Thermal Therapy of Cancer Thermal Therapy of Cancer Paul Stauffer Chris Diederich Jean Pouliot Radiation Oncology Dept. University of California, San Francisco [email protected]Paul Stauffer Chris Diederich Jean Pouliot Radiation Oncology Dept. University of California, San Francisco [email protected]UC UC SF SF
35
Embed
Thermal Therapy of Cancer - American Association of ... Therapy of CancerThermal Therapy of Cancer ... Thermal Therapy Treatment OptionsThermal Therapy Treatment Options Cryotherapy
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Thermal Therapy of CancerThermal Therapy of CancerThermal Therapy of Cancer
Paul StaufferChris Diederich
Jean Pouliot
Radiation Oncology Dept.University of California, San Francisco
Dose = Cumulative Equivalent Minutes at 43°C for the T90 temperature
(CEM43oCT)
Hyperthermia
T = 41-45°C for 30-60 minΔT = 4 - 8°C
Dose = Cumulative Equivalent Minutes at 43°C for the T90 temperature
(CEM43oCT)
Hyperthermia Mechanisms
• Increases perfusion, permeability, pH, pO2
• Increases metabolic activity, drug uptake
• Radiosensitization, Chemosensitization
• Some cell kill at higher temperatures/doses
Hyperthermia Mechanisms
• Increases perfusion, permeability, pH, pO2
• Increases metabolic activity, drug uptake
• Radiosensitization, Chemosensitization
• Some cell kill at higher temperatures/doses
Hyperthermia RationaleHyperthermia Rationale
C3H Mammary Carcinoma
(a) (b) (c) Fig. 2 – Rationale for combining heat and radiation for treatment of recurrent chestwall disease. Data from demonstrates: (a) increased TER for simultaneous heat and radiation in C3H mammary carcinoma, (b) clinical impact of TER=1.5 obtained from a compilation of human data in the literature, and (c) TER up to 5.0 for simultaneous heat and radiation in C3H mammary carcinoma compared to TER plateau of 2.0 for sequentially applied modalities.
The synergistic effect of heat and radiation is quantified by the Thermal Enhancement Ratio (TER) defined as:The synergistic effect of heat and radiation is quantified by the Thermal Enhancement Ratio (TER) defined as:
TER =RT dose without heat
RT dose for equivalent effect with heat
DosimetryDosimetry
Body is thermally auto-regulated
Heating an organ is like bringing a heater in an air conditioned room!
Feedback Control / Power Steering
Heating deviceHeating device Temperature elevationTemperature elevation
Evolving Technologies – Deep HeatingEvolving Technologies – Deep Heating
19821982
4 Antenna Pairs1 Ring
Sigma 60
12 Ch, 24 Antennas3 Rings
Sigma-Eye
1 Power Channel
RF- 8
Magnetrode
APAS
InterstitialInterstitial
Multi-needle LCF hyperthermia systemdesigned for hyperthermia combined with brachytherapy. (Photos courtesy of Peter Corry, William Beaumont Hospital).
Multi-needle LCF hyperthermia systemdesigned for hyperthermia combined with brachytherapy. (Photos courtesy of Peter Corry, William Beaumont Hospital).
Interstitial microwave antennas suitable for hyperthermia in combination with interstitial brachytherapy (with permission from BSD Medical Corp.).
Interstitial microwave antennas suitable for hyperthermia in combination with interstitial brachytherapy (with permission from BSD Medical Corp.).
(A) Interstitial ultrasound applicators suitable for heating in combination with HDR brachytherapy; (B) CT image of a brachytherapy implant pattern in the prostate, with directional ultrasound applicators placed posterior with energy directed anterior to protect the rectum. (C) Measured temperature profiles.
(A) Interstitial ultrasound applicators suitable for heating in combination with HDR brachytherapy; (B) CT image of a brachytherapy implant pattern in the prostate, with directional ultrasound applicators placed posterior with energy directed anterior to protect the rectum. (C) Measured temperature profiles.
First Simple Structures (e.g. Single Waveguide, Piston)Centrally Peaked SAR - Power Up / Down ControlNo pre-Tx planning or real-time adjustment of SAR1-8 Stationary Temperature SensorsSmall Treatment Volumes (e.g. < 3-4 cm diameter)
Second Planar Arrays2-D Treatment Planning - Lateral Adjustment of SAR4 - 16 Controllable Sources8 - 16 Temperature Sensors, Thermal MappingModerate Size Treatment Volumes
Emerging Electrically or Physically Phase Focused ArraysStationary Conformal ArraysSite-Optimized ApplicatorsNon-Invasive Temperature & Physiologic Effect MonitoringPatient Specific Treatment Planning - 3-D Power Steering
Generation
1980’s1980’s
1990’s1990’s
20002000
So Why Isn’t Everyone Offering HT(Depends on Who You Talk To)
So Why Isn’t Everyone Offering HT(Depends on Who You Talk To)
Reimbursement rate too low AdministratorsSpace and personnel demands too high Administrators
Can not heat all patients/sites CliniciansCan not deliver precise Tdose as prescribed Clinicians
Equipment is terrible PhysicistsBetter equipment not available commercially Physicists
Difficult to setup and deliver in many sites OperatorsUncomfortable for some patients Operators
• Optimum combination of HT with RT
Long duration moderate vs. short duration high temp. HTPulsed vs. continuous RT with simultaneous HT
• Optimum administration of HT with CT
Identify best compromise of temperature/thermal dose forVessel permeability, extravasation, cell metabolism and uptake
• Are we investigating all appropriate clinical applications
Can we justify treating earlier stage disease/whichMore aggressive combinations of HT + RT + CT
Current Challenges - BiologyCurrent Challenges - Biology